{
  "Assay": [
    {
      "name": "pncA",
      "Target": {
        "end_position": "746",
        "function": "resistance type",
        "gene_name": "pncA",
        "Amplicon": {
          "sequence": "GGCGTCATGGACCCTATATCTGTGGCTGCCGCGTCGGTAGGCAAACTGCCCGGGCAGTCGCCCGAACGTATGGTGGACGTATGCGGGCGTTGATCATCGTCGACGTGCAGAACGACTTCTGCGAGGGTGGCTCGCTGGCGGTAACCGGTGGCGCCGCGCTGGCCCGCGCCATCAGCGACTACCTGGCCGAAGCGGCGGACTACCATCACGTCGTGGCAACCAAGGACTTCCACATCGACCCGGGTGACCACTTCTCCGGCACACCGGACTATTCCTCGTCGTGGCCACCGCATTGCGTCAGCGGTACTCCCGGCGCGGACTTCCATCCCAGTCTGGACACGTCGGCAATCGAGGCGGTGTTCTACAAGGGTGCCTACACCGGAGCGTACAGCGGCTTCGAAGGAGTCGACGAGAACGGCACGCCACTGCTGAATTGGCTGCGGCAACGCGGCGTCGATGAGGTCGATGTGGTCGGTATTGCCACCGATCATTGTGTGCGCCAGACGGCCGAGGACGCGGTACGCAATGGCTTGGCCACCAGGGTGCTGGTGGACCTGACAGCGGGTGTGTCGGCCGATACCACCGTCGCCGCGCTGGAGGAGATGCGCACCGCCAGCGTCGAGTTGGTTTGCAGCTCCTGATGGCACCGCCGAACCGGGATGAACTGTTGGCGGCGGTGGAGCGCTCGCCGCAAGCGGCCGCCGCGCACGACCGCGCCGGCTGGGTCGGGTTGTTCACCGGTGACGCGCGGGTCGAAGACCCGGTGGGTTCGCAGCCGCAGGTGGGGCATGAGGCCATCGGCCGCTTCTACGACACCTTCATCGGG",
          "RegionOfInterest": [
            {
              "name": "pncA_amplicon1",
              "position_range": "3-150",
              "nt_sequence": "CGTCATGGACCCTATATCTGTGGCTGCCGCGTCGGTAGGCAAACTGCCCGGGCAGTCGCCCGAACGTATGGTGGACGTATGCGGGCGTTGATCATCGTCGACGTGCAGAACGACTTCTGCGAGGGTGGCTCGCTGGCGGTAACCGGTG",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA1F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon2",
              "position_range": "72-220",
              "nt_sequence": "GGTGGACGTATGCGGGCGTTGATCATCGTCGACGTGCAGAACGACTTCTGCGAGGGTGGCTCGCTGGCGGTAACCGGTGGCGCCGCGCTGGCCCGCGCCATCAGCGACTACCTGGCCGAAGCGGCGGACTACCATCACGTCGTGGCAAC",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA2F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon3",
              "position_range": "189-337",
              "nt_sequence": "GAAGCGGCGGACTACCATCACGTCGTGGCAACCAAGGACTTCCACATCGACCCGGGTGACCACTTCTCCGGCACACCGGACTATTCCTCGTCGTGGCCACCGCATTGCGTCAGCGGTACTCCCGGCGCGGACTTCCATCCCAGTCTGGA",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA3F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon4",
              "position_range": "291-440",
              "nt_sequence": "CATTGCGTCAGCGGTACTCCCGGCGCGGACTTCCATCCCAGTCTGGACACGTCGGCAATCGAGGCGGTGTTCTACAAGGGTGCCTACACCGGAGCGTACAGCGGCTTCGAAGGAGTCGACGAGAACGGCACGCCACTGCTGAATTGGCTG",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA4F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon5",
              "position_range": "357-505",
              "nt_sequence": "GTGTTCTACAAGGGTGCCTACACCGGAGCGTACAGCGGCTTCGAAGGAGTCGACGAGAACGGCACGCCACTGCTGAATTGGCTGCGGCAACGCGGCGTCGATGAGGTCGATGTGGTCGGTATTGCCACCGATCATTGTGTGCGCCAGAC",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA5F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon6",
              "position_range": "450-598",
              "nt_sequence": "GGCGTCGATGAGGTCGATGTGGTCGGTATTGCCACCGATCATTGTGTGCGCCAGACGGCCGAGGACGCGGTACGCAATGGCTTGGCCACCAGGGTGCTGGTGGACCTGACAGCGGGTGTGTCGGCCGATACCACCGTCGCCGCGCTGGA",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA6F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            },
            {
              "name": "pncA_amplicon7",
              "position_range": "577-725",
              "nt_sequence": "ATACCACCGTCGCCGCGCTGGAGGAGATGCGCACCGCCAGCGTCGAGTTGGTTTGCAGCTCCTGATGGCACCGCCGAACCGGGATGAACTGTTGGCGGCGGTGGAGCGCTCGCCGCAAGCGGCCGCCGCGCACGACCGCGCCGGCTGGG",
              "Significance": {
                "resistance": "Pyrazinamide",
                "message": "pncA7F + 150nt - mutation present which may be associated with pyrazinamide resistance."
              }
            }
          ]
        },
        "start_position": "-80"
      },
      "assay_type": "ROI"
    },
    {
      "name": "eis",
      "Target": {
        "end_position": "240",
        "function": "resistance type",
        "gene_name": "eis",
        "Amplicon": {
          "sequence": "CGTCGCTGATTCTCGCAGTGGCGTCACGCTGGCGGGGCTACCCGCATCGCGTGATCCTTTGCCAGACACTGTCGTCGTAATATTCACGTGCACGTGGCCGCGGCATATGCCACAGTCGGATTCTGTGACTGTGACCCTGTGTAGCCCGACCGAGGACGACTGGCCGGGGATGTTCCTACTGGCCGCGGCCAGTTTCACCGATTTCATCGGCCCTGAATCAGCGACCGCCTGGCGGACCCTGGTGCCCACCGACGGAGCGGTGGTGGTCCGCGATGGTGCCGGCCCGGGTTCTGAGGTGGTCGGGATGGCGCTGTACATGGATCTGCGGTTGACGGTGCCTGGTGAAGTGGTGCTCCCGACCGCC",
          "SNP": [
            {
              "reference": "G",
              "position": 115,
              "variant": "A",
              "name": "-10A",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -10 mutation present which is associated with kanamycin resistance."
              }
            },
            {
              "reference": "C",
              "position": 113,
              "variant": "T",
              "name": "-12T",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -12 mutation present which is associated with kanamycin resistance."
              }
            },
            {
              "reference": "C",
              "position": 111,
              "variant": "T",
              "name": "-14T",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -14 mutation present which is associated with kanamycin resistance."
              }
            },
            {
              "reference": "C",
              "position": 110,
              "variant": "G",
              "name": "-15G",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -15 mutation present which is associated with kanamycin resistance."
              }
            },
            {
              "reference": "G",
              "position": 88,
              "variant": "T",
              "name": "-37T",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -37 mutation present which is associated with kanamycin resistance."
              }
            },
            {
              "reference": "A",
              "position": 82,
              "variant": "T",
              "name": "-43T",
              "Significance": {
                "resistance": "Kanamycin",
                "message": "eis -43 mutation present which is associated with kanamycin resistance."
              }
            }
          ]
        },
        "start_position": "-124"
      },
      "assay_type": "SNP"
    },
    {
      "name": "gyrA",
      "Target": {
        "end_position": "550",
        "function": "resistance type",
        "gene_name": "gyrA",
        "Amplicon": {
          "sequence": "ATCGACTATGCGATGAGCGTGATCGTCGGCCGCGCGCTGCCGGAGGTGCGCGACGGGCTCAAGCCCGTGCATCGCCGGGTGCTCTATGCAATGTTCGATTCCGGCTTCCGCCCGGACCGCAGCCACGCCAAGTCGGCCCGGTCGGTTGCCGAGACCATGGGCAACTACCACCCGCACGGCGACGCGTCGATCTACGACAGCCTGGTGCGCATGGCCCAGCCCTGGTCGCTGCGCTACCCGCTGGTGGACGGCCAGGGCAACTTCGGCTCGCCAGGCAATGACCCACCGGCGGCGATGAGGTACACCGAAGCCCGGCTGACCCCGTTGGCGATGGAGATGCTGAGGGAAATCGACGAGGAGACAGTCGATTTCATCCCTAACTACGACGGCCGGGTGCAAGAGCCGACGGTGCTACCCAGCCGGTTCCCCAACCTGCTGGCCAACGGGTCAGGCGGCATCGCGGTCG",
          "RegionOfInterest": [
            {
              "mutations": "GCC,GTG,TGC",
              "name": "88",
              "position_range": "178-180",
              "nt_sequence": "GGC",
              "Significance": {
                "resistance": "Quinolones",
                "message": "gyrA 88 mutation present which is associated with resistance to quinolones, but Moxifloxacin may still have clinical activity. Testing for MOX MIC is recommended."
              }
            },
            {
              "mutations": "CCG",
              "name": "91",
              "position_range": "187-189",
              "nt_sequence": "TCG",
              "Significance": {
                "resistance": "Quinolones",
                "message": "gyrA 91 mutation present which is associated with resistance to quinolones, but Moxifloxacin may still have clinical activity. Testing for MOX MIC is recommended."
              }
            },
            {
              "mutations": "GGC,AAC,CAC,GCC,TAC",
              "name": "94",
              "position_range": "196-198",
              "nt_sequence": "GAC",
              "Significance": {
                "resistance": "Quinolones",
                "message": "gyrA 94 mutation present which is associated with resistance to quinolones, but Moxifloxacin may still have clinical activity. Testing for MOX MIC is recommended."
              }
            }
          ]
        },
        "start_position": "85"
      },
      "assay_type": "ROI"
    },
    {
      "name": "inhA",
      "Target": {
        "end_position": "233",
        "function": "resistance type",
        "gene_name": "inhA",
        "Amplicon": {
          "sequence": "CCTCGCTGCCCAGAAAGGGATCCGTCATGGTCGAAGTGTGCTGAGTCACACCGACAAACGTCACGAGCGTAACCCCAGTGCGAAAGTTCCCGCCGGAAATCGCAGCCACGTTACGCTCGTGGACATACCGATTTCGGCCCGGCCGCGGCGAGACGATAGGTTGTCGGGGTGACTGCCACAGCCACTGAAGGGGCCAAACCCCCATTCGTATCCCGTTCAGTCCTGGTTACCGGAGGAAACCGGGGGATCGGGCTGGCGATCGCACAGCGGCTGGCTGCCGACGGCCACAAGGTGGCCGTCACCCACCGTGGATCCGGAGCGCCAAAGGGGCTGTTTGGCGTCGAATGTGACGTCACCGACAGCGACGCCGTCGATCGCGCCTTCACGGCGGTAGAAGAGCA",
          "SNP": [
            {
              "reference": "T",
              "position": 161,
              "variant": "A",
              "name": "-8A",
              "Significance": {
                "resistance": "Isoniazid",
                "message": "inhA -8 mutation present which is associated with isoniazid resistance."
              }
            },
            {
              "reference": "T",
              "position": 161,
              "variant": "C",
              "name": "-8C",
              "Significance": {
                "resistance": "Isoniazid",
                "message": "inhA -8 mutation present which is associated with isoniazid resistance."
              }
            },
            {
              "reference": "T",
              "position": 161,
              "variant": "G",
              "name": "-8G",
              "Significance": {
                "resistance": "Isoniazid",
                "message": "inhA -8 mutation present which is associated with isoniazid resistance."
              }
            },
            {
              "reference": "C",
              "position": 154,
              "variant": "T",
              "name": "-15T",
              "Significance": {
                "resistance": "Isoniazid",
                "message": "inhA -15 mutation present which is associated with isoniazid resistance."
              }
            },
            {
              "reference": "G",
              "position": 152,
              "variant": "T",
              "name": "-17T",
              "Significance": {
                "resistance": "Isoniazid",
                "message": "inhA -17 mutation present which is associated with isoniazid resistance."
              }
            }
          ]
        },
        "start_position": "-168"
      },
      "assay_type": "SNP"
    },
    {
      "name": "katG",
      "Target": {
        "end_position": "1190",
        "function": "resistance type",
        "gene_name": "katG",
        "Amplicon": {
          "sequence": "GCGGCGGTCGACATTCGCGAGACGTTTCGGCGCATGGCCATGAACGACGTCGAAACAGCGGCGCTGATCGTCGGCGGTCACACTTTCGGTAAGACCCATGGCGCCGGCCCGGCCGATCTGGTCGGCCCCGAACCCGAGGCTGCTCCGCTGGAGCAGATGGGCTTGGGCTGGAAGAGCTCGTATGGCACCGGAACCGGTAAGGACGCGATCACCAGCGGCATCGAGGTCGTATGGACGAACACCCCGACGAAATGGGACAACAGTTTCCTCGAGATCCTGTACGGCTACGAGTGGGAGCTGACGAAGAGCCCTGCTGGCGCTTGGCAATACACCGCCAAGGACGGCGCCGGTGCCGGCACCATCCCGGACCCGTTCGGCGGGCCAGGGCGCTCCCCGACGATGCTGGCCACTGACCTCTCGCTGCGGGTGGATCCGATCTATGAGCGGATCACGCGTCGCTG",
          "RegionOfInterest": {
            "mutations": "ACC,AAC,ACA,AGA",
            "name": "315",
            "position_range": "214-216",
            "nt_sequence": "AGC",
            "Significance": {
              "resistance": "Isoniazid",
              "message": "katG 315 mutation present which is associated with isoniazid resistance."
            }
          }
        },
        "start_position": "730"
      },
      "assay_type": "ROI"
    },
    {
      "name": "rpoB",
      "Target": {
        "end_position": "1580",
        "function": "resistance type",
        "gene_name": "rpoB",
        "Amplicon": {
          "sequence": "ACCAGATCCGGGTCGGCATGTCGCGGATGGAGCGGGTGGTCCGGGAGCGGATGACCACCCAGGACGTGGAGGCGATCACACCGCAGACGTTGATCAACATCCGGCCGGTGGTCGCCGCGATCAAGGAGTTCTTCGGCACCAGCCAGCTGAGCCAATTCATGGACCAGAACAACCCGCTGTCGGGGTTGACCCACAAGCGCCGACTGTCGGCGCTGGGGCCCGGCGGTCTGTCACGTGAGCGTGCCGGGCTGGAGGTCCGCGACGTGCACCCGTCGCACTACGGCCGGATGTGCCCGATCGAAACCCCTGAGGGGCCCAACATCGGTCTGATCGGCTCGCTGTCGGTGTACGCGCGGGTCAACCCGTTCGGGTTCATCGAAACGCCGTACCGCAAGGTGGTCGACGGCGTGGTTAGCGACGA",
          "RegionOfInterest": [
            {
              "mutations": "AAA,CTA",
              "name": "513",
              "position_range": "153-155",
              "nt_sequence": "CAA",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 513 mutation present which is associated with rifampin resistance."
              }
            },
            {
              "mutations": "TAC,GTC,GGC",
              "name": "516",
              "position_range": "162-164",
              "nt_sequence": "GAC",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 516 mutation present which is associated with rifampin resistance."
              }
            },
            {
              "mutations": "TTG",
              "name": "522",
              "position_range": "180-182",
              "nt_sequence": "TCG",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 522 mutation present which is associated with rifampin resistance."
              }
            },
            {
              "mutations": "GAC,TAC,CGC,CTC,AAC,TGC",
              "name": "526",
              "position_range": "192-194",
              "nt_sequence": "CAC",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 526 mutation present which is associated with rifampin resistance."
              }
            },
            {
              "mutations": "TTG,TGG",
              "name": "531",
              "position_range": "207-209",
              "nt_sequence": "TCG",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 531 mutation present which is associated with rifampin resistance."
              }
            },
            {
              "mutations": "CCG",
              "name": "533",
              "position_range": "213-215",
              "nt_sequence": "CTG",
              "Significance": {
                "resistance": "Rifampin",
                "message": "rpoB 533 mutation present which is associated with rifampin resistance."
              }
            }
          ]
        },
        "start_position": "1160"
      },
      "assay_type": "ROI"
    },
    {
      "name": "rrs",
      "Target": {
        "end_position": "1690",
        "function": "resistance type",
        "gene_name": "rrs",
        "Amplicon": {
          "sequence": "CCTTAAAAGCCGGTCTCAGTTCGGATCGGGGTCTGCAACTCGACCCCGTGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCATGAAAGTCGGTAACACCCGAAGCCAGTGGCCTAACCCTCGGGAGGGAGCTGTCGAAGGTGGGATCGGCGATTGGGACGAAGTCGTAACAAGGTAGCCGTACCGGAAGGTGCGGCTGGATCACCTCCTTTCTAAGGAGCACCACGAAAACGCCCCAACTGGTGGGGCGTAGGCCGTGAGGGGTTCTTGTCTGTAGTGGGCGAGAGCCGGGTGCATGACAACAAAGTTGGCCACCAACACACTGTTGGGTCCTGAGGCAACACTCGGACTTGTTCCAGGTGTTGT",
          "SNP": [
            {
              "reference": "A",
              "position": 128,
              "variant": "G",
              "name": "1401G",
              "Significance": {
                "resistance": "Kanamycin, Capreomycin, Amikacin",
                "message": "rrs 1401 mutation present which is associated with kanamycin, capreomycin, and amikacin resistance. Specificity for Capreomycin is about 96%, 3-4% of isolates with this mutation may be sensitive to CAP."
              }
            },
            {
              "reference": "C",
              "position": 129,
              "variant": "T",
              "name": "1402T",
              "Significance": {
                "resistance": "Capreomycin",
                "message": "rrs 1402 mutation present which is associated with capreomycin resistance."
              }
            },
            {
              "reference": "A",
              "position": 189,
              "variant": "C",
              "name": "1462C",
              "Significance": {
                "resistance": "Kanamycin, Capreomycin, Amikacin",
                "message": "rrs 1462 mutation present which is associated with kanamycin, capreomycin, and amikacin resistance."
              }
            },
            {
              "reference": "G",
              "position": 211,
              "variant": "T",
              "name": "1484T",
              "Significance": {
                "resistance": "Capreomycin, Amikacin",
                "message": "rrs 1484 mutation present which is associated with capreomycin and amikacin resistance."
              }
            },
            {
              "reference": "A",
              "position": 213,
              "variant": "T",
              "name": "1486T",
              "Significance": {
                "resistance": "Kanamycin, Capreomycin, Amikacin",
                "message": "rrs 1486 mutation present which is associated with kanamycin, capreomycin, and amikacin resistance."
              }
            }
          ]
        },
        "start_position": "1275"
      },
      "assay_type": "SNP"
    },
    {
      "name": "IPSC",
      "Target": {
        "end_position": "261",
        "function": "resistance type",
        "gene_name": "IPSC",
        "Amplicon": {
          "sequence": "GGGCGGACGAAAACCCTTGAGCACAGAAATTGAGCAGAGGCTAGTCGCGTGATATGACTTAAGATTTGGGTCTGTACGGCTATAGTTTGGTGAGTTAAGCTGGATCGGGAGTTTGCAAGACGATCTGGCACAGTTAGTCACAGACGAAGGACTCACTTTGGAAAGGCGGCTTCGGCCGCCAATCTTGGATCCCAGCGGAAGCAGGAACCGTTGAGGCCAGAGGAATACGTCCGTCATTGCGTCTAGGTAAGGCATCCCGGC",
          "Significance": {
            "message": "Internal Positive Sequencing Control (IPSC)"
          }
        },
        "start_position": "1"
      },
      "assay_type": "presence/absence"
    }
  ]
}